Dr. Shantanu Gaur is the Founder and Chief Scientific Officer of Allurion Technologies. Shantanu founded Allurion in 2009 to develop disruptive devices for the weight loss industry that are more effective than diet and exercise but safer, cheaper, and more accessible than weight loss surgery. Allurion’s flagship product—Elipse™—is the world’s first procedureless gastric balloon for weight loss and is now available for commercial sale in Europe. Shantanu also serves as a board member for Genetic Alliance, a non-profit committed to putting the participant back at the center of healthcare. Shantanu graduated summa cum laude with a B.S. in Biology from Harvard College and with an M.D. from Harvard Medical School where he was Paul & Daisy Soros Fellow. He lives in Cambridge, MA with his wife Neha, who is a Type 1 Diabetic.